Avotaciclib (BEY1107) 是一种有效和具有口服活性的cyclin dependent kinase 1 (CDK1)抑制剂。Avotaciclib 可用于局部晚期或转移性胰腺癌的研究。
| 生物活性 | Avotaciclib (BEY1107) is a potent and orally active inhibitor ofcyclin dependent kinase 1 (CDK1). Avotaciclib can be used for the research of locally advanced or metastatic pancreaticcancer[1]. |
| IC50& Target[1] | |
| Clinical Trial | |
| 分子量 | |
| Formula | |
| CAS 号 | |
| 运输条件 | Room temperature in continental US; may vary elsewhere. |
| 储存方式 | Please store the product under the recommended conditions in the Certificate of Analysis. |
